Skip to main content
Article
Using 124I-PU-H71 PET imaging to predict intratumoral concentration in patients on a phase I trial of PU-H71.
Journal of Clinical Oncology (2017)
  • John F. Gerecitano, Memorial Sloan Kettering Cancer Center
  • Shanu Modi, Memorial Sloan Kettering Cancer Center
  • Devika Gajria, Memorial Sloan Kettering Cancer Center
  • Tony Taldone, Memorial Sloan Kettering Cancer Center
  • Mary Alpaugh, Memorial Sloan Kettering Cancer Center
  • Erica Gomes DaGama, Memorial Sloan Kettering Cancer Center
  • Mohammad Uddin, Memorial Sloan Kettering Cancer Center
  • Gabriela Chiosis, Kettering University
  • Jason Stuart Lewis, Memorial Sloan Kettering Cancer Center
  • Steven M. Larson, Memorial Sloan Kettering Cancer Center
  • Naga Vara Kishore Pillarsetty, Memorial Sloan Kettering Cancer Center
  • Komal L. Jhaveri, Memorial Sloan Kettering Cancer Center
  • Brian Krichevsky
  • Mei Hsuan Chen
  • Payal Dixit
  • Mark Dunphy, Kettering University
Publication Date
January 30, 2017
Citation Information
John F. Gerecitano, Shanu Modi, Devika Gajria, Tony Taldone, et al.. "Using 124I-PU-H71 PET imaging to predict intratumoral concentration in patients on a phase I trial of PU-H71." Journal of Clinical Oncology (2017)
Available at: http://works.bepress.com/mary-alpaugh/10/